Maintenance immunosuppressive therapy in autoimmune hepatitis: To stop or not to stop, that is the question

Eur J Intern Med. 2021 Aug:90:25-26. doi: 10.1016/j.ejim.2021.05.005. Epub 2021 May 21.

Authors

Mark F J Stolk¹, Aad P van den Berg², Karel J van Erpecum³

Affiliations

¹ Department of Gastroenterology, St Antonius Hospital Nieuwegein, the Netherlands. Electronic address: m.stolk@antoniusziekenhuis.nl.
² Department of Gastroenterology and Hepatology and Institute for Organ Transplantation (GIOT). University Medical Center Groningen, Groningen, the Netherlands.
³ Department of Gastroenterology and Hepatology University Medical Center Utrecht, Utrecht, the Netherlands.

PMID: 34024702
DOI: 10.1016/j.ejim.2021.05.005

No abstract available

Keywords: Autoimmune hepatitis; Immunosuppression; Relapse; Withdrawal.

Publication types

Comment

MeSH terms

Azathioprine / therapeutic use
Hepatitis, Autoimmune* / drug therapy
Humans
Immunosuppressive Agents / therapeutic use

Substances

Immunosuppressive Agents
Azathioprine